Remove 2026 Remove Musculoskeletal Remove Treatment
article thumbnail

restor3d Secures $38 Million in Growth Capital to Drive Expansion and Innovation in Personalized Orthopedic Solutions

OrthoSpineNews

The investments will fuel the companys continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment.